BEKE three-lens brief
Evidence-based stock research on BEKE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Earnings in 4 days (2026-11-16).
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Analyst mean target $24.04 — 34% above current (20 analysts).
- Earnings in 4 days (2026-11-16).
BEKE closed at $17.96 (-0.77%) as of 2026-11-12. Market cap: $19.68B. P/E (trailing) 29.9. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; analyst mean target $24.04 — 34% above current (20 analysts).. Concerns: earnings in 4 days (2026-11-16).. Last quarter: Revenue $24.54B, net income $2.62B, free cash flow $4.35B. Watching for: 2026-11-16 earnings release (4 days out).
Why three lenses on BEKE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BEKE across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BEKE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BEKE brief"></iframe>